Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | 2,045,730 | reported | 06 Mar 2026 | tx 55+3,383,502−2,267,301 |
| TAPIMMUNE INC | 137,330 | reported | 17 Nov 2025 | tx 10+1,535,863 |
| Zosano Pharma Corp | 22,500 | reported | 10 Jun 2021 | tx 7+522,571 |
| MAP Pharmaceuticals, Inc. | 7,500 | reported | 20 May 2010 | tx 5+15,002−4,178 |
| AMBIT BIOSCIENCES CORP | 2,362 | reported | 02 Sept 2014 | tx 17+1,662,661−24,060,039 |
| Cidara Therapeutics, Inc. | 0 | reported | 20 Apr 2015 | tx 2+351,518−8,928,572 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 16+3,314,785−5,440,628 |
| GOLF TRUST OF AMERICA INC | 0 | reported | 26 May 2016 | tx 6+2,640,000 |
| Elevation Oncology, Inc. | 0 | reported | 23 Jul 2025 | tx 7+70,000−148,095 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | PURCHASE | ADMA BIOLOGICS, INC. | 7,000 | 15.67 USD | first after silence |
| 06 Mar 2026 | PURCHASE | ADMA BIOLOGICS, INC. | 7,000 | 15.39 USD | |
| 09 Feb 2026 | GRANT_AWARD | ADMA BIOLOGICS, INC. | 10,690 | 0.00 USD | |
| 09 Feb 2026 | GRANT_AWARD | ADMA BIOLOGICS, INC. | 17,730 | 0.00 USD | deriv |
| 17 Nov 2025 | GRANT_AWARD | TAPIMMUNE INC | 84,411 | 0.00 USD | deriv |
| 17 Nov 2025 | GRANT_AWARD | TAPIMMUNE INC | 137,330 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 35,000 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 35,000 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 31,238 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 15,619 | 0.00 USD | deriv |
| 23 Jul 2025 | OTHER | Elevation Oncology, Inc. | 31,238 | 0.00 USD | deriv |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 53,837 | 3.66 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 37,541 | 5.40 USD | |
| 16 Jun 2025 | SALE | ADMA BIOLOGICS, INC. | 194,749 | 20.24 USD | |
| 13 Jun 2025 | SALE | ADMA BIOLOGICS, INC. | 137,931 | 20.82 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 17,500 | 4.91 USD | |
| 12 Jun 2025 | SALE | ADMA BIOLOGICS, INC. | 92,941 | 21.69 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 9,000 | 5.96 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 10,000 | 5.00 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 51,630 | 3.35 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 53,172 | 1.67 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 55,000 | 2.35 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 15,000 | 2.92 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 30,000 | 3.89 USD | |
| 13 Jun 2025 | EXERCISE | ADMA BIOLOGICS, INC. | 15,000 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 05 Mar 2026.